Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...
Dan Skovronsky, Eli Lilly Chief Scientific Officer, joins 'Fast Money' to talk Zepbound's recent trial results and what it ...
Leerink Partners analyst David Risinger has reiterated their bullish stance on LLY stock, giving a Buy rating on December 2.Don't Miss our ...
The initial rollout of Eli Lilly's weight loss drug Zepbound in the UK will first go to those with the great clinical need ...
Trump Organization Plans an Ethics Policy Without Banning Foreign Deals The Trump family business is expected to announce some restrictions on transactions, but is not likely to accept as many as ...
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
We’ve attempted to pull together a comprehensive 100-1 list of the Top 100 Men’s Rugby Players, bolstered by a team of esteeme… Fiji are back on top of the Sevens world after an undefeated opening ...
Royal Caribbean has added travel routers to its prohibited items list and has begun confiscating the tech devices.